Clinical trial
The AttenueX IntraVesical System for the Treatment of Female Stress Urinary…
NCT00492596 · Solace Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT00492596 |
|---|---|
| Title | The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence |
| Official title | An Evaluation of the AttenueX IntraVesical System in the Management of Female Subjects With Stress Urinary Incontinence |
| Lead sponsor | Solace Therapeutics, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence, Stress |
| Intervention type | Device, Procedure |
| Interventions | AttenueX IntraVesical System, Sham Procedure |
| Enrollment | 166 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Jun 27, 2007 |
| Last update posted | Aug 11, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: